CRIS Current Research Information System

MUCCIOLI, LORENZO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 3.993
NA - Nord America 2.916
EU - Europa 2.129
SA - Sud America 218
Continente sconosciuto - Info sul continente non disponibili 213
AF - Africa 197
OC - Oceania 3
Totale 9.669
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.826
VN - Vietnam 1.100
SG - Singapore 964
CN - Cina 902
IT - Italia 842
HK - Hong Kong 264
SE - Svezia 259
DE - Germania 223
BD - Bangladesh 171
NL - Olanda 168
KR - Corea 159
BR - Brasile 158
GB - Regno Unito 151
IN - India 134
FR - Francia 114
CI - Costa d'Avorio 90
RU - Federazione Russa 79
IE - Irlanda 74
JP - Giappone 66
FI - Finlandia 51
CA - Canada 48
JO - Giordania 43
ID - Indonesia 34
PH - Filippine 29
BG - Bulgaria 28
AT - Austria 25
ZA - Sudafrica 25
NG - Nigeria 23
TH - Thailandia 23
MX - Messico 22
CH - Svizzera 21
IQ - Iraq 20
AR - Argentina 19
TR - Turchia 18
TG - Togo 15
SC - Seychelles 14
CO - Colombia 13
PK - Pakistan 13
UA - Ucraina 13
ES - Italia 12
TW - Taiwan 12
EC - Ecuador 11
PL - Polonia 11
BE - Belgio 9
GR - Grecia 9
JM - Giamaica 6
SA - Arabia Saudita 6
UZ - Uzbekistan 6
LT - Lituania 5
RO - Romania 5
AZ - Azerbaigian 4
CL - Cile 4
DK - Danimarca 4
EG - Egitto 4
HR - Croazia 4
IL - Israele 4
MA - Marocco 4
MY - Malesia 4
PY - Paraguay 4
AU - Australia 3
CG - Congo 3
CM - Camerun 3
CZ - Repubblica Ceca 3
EE - Estonia 3
LB - Libano 3
NP - Nepal 3
PE - Perù 3
PT - Portogallo 3
RS - Serbia 3
SV - El Salvador 3
TN - Tunisia 3
TT - Trinidad e Tobago 3
VE - Venezuela 3
BH - Bahrain 2
CR - Costa Rica 2
DZ - Algeria 2
GH - Ghana 2
GT - Guatemala 2
IR - Iran 2
KE - Kenya 2
KZ - Kazakistan 2
LV - Lettonia 2
NI - Nicaragua 2
SI - Slovenia 2
SO - Somalia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BJ - Benin 1
BO - Bolivia 1
BS - Bahamas 1
BY - Bielorussia 1
DJ - Gibuti 1
HU - Ungheria 1
KH - Cambogia 1
LU - Lussemburgo 1
ML - Mali 1
MM - Myanmar 1
MN - Mongolia 1
Totale 9.450
Salva come PNG Salva come JPEG
Città #
Singapore 692
Ashburn 407
Hefei 336
Ho Chi Minh City 303
Hanoi 264
Hong Kong 251
San Jose 236
Bologna 160
Chandler 158
Seoul 151
Santa Clara 114
Beijing 98
Fairfield 97
Southend 95
Abidjan 90
Los Angeles 79
Boardman 77
Dallas 76
New York 76
Council Bluffs 75
Milan 75
Dublin 74
Houston 58
Tokyo 57
Ann Arbor 55
Princeton 55
Lauterbourg 51
Seattle 48
Dong Ket 44
Wilmington 44
Woodbridge 44
Amman 43
Cambridge 42
Haiphong 39
Rome 37
Turin 37
Da Nang 36
Florence 35
Modena 35
Munich 32
São Paulo 31
Bengaluru 30
Redondo Beach 29
Frankfurt am Main 28
Helsinki 28
Sofia 27
Amsterdam 26
Fort Wayne 22
Nuremberg 22
Abeokuta 21
Buffalo 20
Redmond 20
Bern 18
Chicago 18
Jakarta 18
Johannesburg 18
Phoenix 18
Hải Dương 17
Vienna 17
Biên Hòa 16
Lappeenranta 16
Montreal 16
Rimini 16
Shanghai 16
Thái Nguyên 16
Lomé 15
Ha Long 14
London 14
Naples 14
Quận Bình Thạnh 14
Atlanta 13
Bắc Giang 13
Des Moines 13
Düsseldorf 13
Tongling 12
Washington 12
Berlin 11
Hyderabad 11
Jinan 11
Mexico City 11
Bắc Ninh 10
Guangzhou 10
Kuban 10
Điện Bàn 10
Boston 9
Brussels 9
Orem 9
Paris 9
San Diego 9
The Dalles 9
Bangkok 8
Boydton 8
Brooklyn 8
Falls Church 8
Medford 8
Perugia 8
Vũng Tàu 8
Warsaw 8
Yubileyny 8
Can Tho 7
Totale 5.664
Salva come PNG Salva come JPEG
Nome #
Prognostic value of pathogenic variants in Lafora Disease: systematic review and meta-analysis of patient-level data 401
Intravenous immunoglobulin therapy in COVID-19-related encephalopathy 230
Ictal Bradycardia and Asystole in Sleep-Related Hypermotor Epilepsy: A Study of 200 Patients 219
CAR t-cell therapy in BOlogNa–NEUrotoxicity TReatment and Assessment in Lymphoma (CARBON–NEUTRAL): proposed protocol and results from an Italian study 211
Epilepsy With Auditory Features: From Etiology to Treatment 209
Acute-onset focal neurological deficits in rheumatoid arthritis: Consider rheumatoid meningitis 207
Genome-wide identification and phenotypic characterization of seizure-associated copy number variations in 741,075 individuals 206
Epilepsy with auditory features: Long-term outcome and predictors of terminal remission 206
Epilepsy with auditory features: Contribution of known genes in 112 patients 204
Encephalopathy in COVID-19 Presenting With Acute Aphasia Mimicking Stroke 198
Blood neurofilament light chain and S100B as biomarkers of neurological involvement and functional prognosis in COVID-19: a multicenter study 193
FDG-PET assessment and metabolic patterns in Lafora disease 193
Neurological Manifestations of Long {COVID}: A Single-Center One-Year Experience 191
Ictal vasodepressive syncope in temporal lobe epilepsy 187
Relationship between plasma concentrations and clinical effects of perampanel: A prospective observational study 187
Juvenile absence epilepsy relapsing as recurrent absence status, mimicking transient global amnesia, in an elderly patient 183
FDG-PET findings and alcohol-responsive myoclonus in a patient with Unverricht-Lundborg disease 181
Treatment with metformin in twelve patients with Lafora disease 179
EEG findings in COVID-19 related encephalopathy 178
A case of clinical worsening after stereo-electroencephalographic-guided radiofrequency thermocoagulation in a patient with polymicrogyria 174
Risk of hospitalization and death for COVID-19 in persons with epilepsy over a 20-month period: The EpiLink Bologna cohort, Italy 173
Peripheral nervous system adverse events associated with immune checkpoint inhibitors 172
Complete Agenesis of Corpus Callosum in KCNQ2-Related Neonatal Epileptic Encephalopathy 165
Epilepsy and inborn errors of metabolism in adults: The diagnostic odyssey of a young woman with medium-chain acyl-coenzyme A dehydrogenase deficiency 164
Erratum: Sub-genic intolerance, ClinVar, and the epilepsies: A whole-exome sequencing study of 29,165 individuals (The American Journal of Human Genetics (2021) 108(6) (965–982), (S0002929721001403), (10.1016/j.ajhg.2021.04.009)) 154
COVID-19-related encephalopathy presenting with aphasia resolving following tocilizumab treatment 153
Secondary sclerosing cholangitis in critically ill patients with febrile infection-related epilepsy syndrome (FIRES): a case series 152
Global, regional, and national burden of stroke and its risk factors, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 152
The Impact of the COVID-19 Pandemic on People With Epilepsy. An Italian Survey and a Global Perspective 152
If seizures left speechless: CA-P-S C-A-R-E, a proposal of a new ictal language evaluation protocol 149
VAL-1221 for the treatment of patients with Lafora disease: Study protocol for a single-arm, open-label clinical trial 145
Polygenic burden in focal and generalized epilepsies 144
MECP2 duplication syndrome: The electroclinical features of a case with long-term evolution 143
Pseudohyperkalemia due to cryohydrocytosis in GLUT1 deficiency syndrome. A case report and literature review 143
Super refractory status epilepticus in Lafora disease interrupted by vagus nerve stimulation: A case report 143
Akinetic mutism in COVID-19-related encephalopathy: A cytokine-mediated maladaptive sickness behavioral response? 138
COVID-19–Associated Encephalopathy and Cytokine-Mediated Neuroinflammation 137
Anti-LGI1 encephalitis following COVID-19 vaccination: a case series 136
SCN1A mutations in focal epilepsy with auditory features: widening the spectrum of GEFS plus 133
Association of CSF and PET markers of neurodegeneration with electroclinical progression in Lafora disease 128
Cognitive and functional connectivity impairment in post-COVID-19 olfactory dysfunction 123
Causes of hospitalization and mortality in persons with epilepsy: The EpiLink Bologna cohort, Italy 123
Natural history of Lafora disease: a prognostic systematic review and individual participant data meta-analysis 118
Exome sequencing of 20,979 individuals with epilepsy reveals shared and distinct ultra-rare genetic risk across disorder subtypes 117
Brain dysfunction in COVID-19 and CAR-T therapy: cytokine storm-associated encephalopathy 109
Sub-genic intolerance, ClinVar, and the epilepsies: A whole-exome sequencing study of 29,165 individuals 101
Low CSF hypocretin-1 levels in an adult patient with hypothalamic hamartoma 99
Effectiveness of perampanel as only concomitant antiseizure medication for highly active epilepsy: insight from a real-world, multicenter retrospective study 98
Fulminant cerebral edema following CAR T-cell therapy: case report and pathophysiological insights from literature review 95
Carotid free-floating thrombus in COVID-19: a cerebrovascular disorder of cytokine storm-related immunothrombosis 95
Genome-wide meta-analysis of over 29,000 people with epilepsy reveals 26 loci and subtype-specific genetic architecture 93
Real-world experience with cannabidiol as add-on treatment in drug-resistant epilepsy 91
Subcortical Myoclonus in Coronavirus Disease 2019: Comprehensive Evaluation of a Patient 88
Clinical course and management challenges in Lafora disease: a narrative analysis in an Apulian cohort 86
Subacute-onset paraneoplastic autonomic neuropathy associated with prostate cancer 84
The In Vivo Diagnosis of Concomitant Alzheimer and Lewy Body Pathology: A Case Report 82
Anti-Ma2-associated limbic encephalitis presenting with transient epileptic amnesia 76
Hemorrhagic cerebral vasculopathy in Susac syndrome 76
EEG as a predictive biomarker of neurotoxicity in anti-CD19 CAR T-cell therapy 71
Neurological Manifestations of Long COVID: A Single-Center One-Year Experience [Response to Letter] 67
Neurofilament Light Chain as a Biomarker of Disease Progression in Lafora Disease 65
Generation of a human induced pluripotent stem cell line (CIBIOi007-A) from a Lafora disease patient 64
State of health and inequalities among Italian regions from 2000 to 2021: a systematic analysis based on the Global Burden of Disease Study 2021 63
Syndrome of inappropriate antidiuresis as a maladaptive stress response shared by coronavirus disease 2019 and other cytokine storm disorders 60
Standard complete blood count to predict long-term outcomes in febrile infection–related epilepsy syndrome (FIRES): A multicenter study 60
The challenge of ultra-rarity: Dual diagnosis of Lafora disease and developmental encephalopathies linked to TRIO and SHANK3 pathogenic variants 60
Empagliflozin Repurposing for Lafora Disease: A Pilot Clinical Trial and Preclinical Investigation of Novel Therapeutic Targets 59
Impact of neurotoxicity and steroid therapy on cancer progression-free survival in lymphoma patients treated with anti-CD19 CAR T cells 58
Sleep and Awake EEG Findings in a Patient with Lafora Disease: From Presymptomatic to Overt Disease Stage 51
New therapeutic strategies for Lafora disease: Evaluation of the safety, efficacy, pharmacokinetics and metabolomic profile of intravenous VAL-1221 treatment 50
Letter to the Editor: “Record-Linkage in Population Studies on Epilepsy: Pros and Cons” 41
Risk of SUDEP during infancy 32
null 1
Totale 9.669
Salva come PNG Salva come JPEG
Categoria #
all - tutte 27.188
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.188
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022648 28 7 30 73 51 26 11 61 36 107 132 86
2022/2023889 81 84 34 67 94 76 32 53 165 38 121 44
2023/2024439 16 42 36 56 38 81 16 57 12 42 24 19
2024/20251.631 69 197 113 99 153 72 72 53 31 198 164 410
2025/20265.239 701 550 399 458 380 179 506 199 878 392 298 299
2026/2027248 248 0 0 0 0 0 0 0 0 0 0 0
Totale 9.669